buspirone has been researched along with Kidney Diseases in 3 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buspirone was not removed by hemodialysis." | 2.37 | Metabolism and disposition of buspirone. ( Gammans, RE; LaBudde, JA; Mayol, RF, 1986) |
| " The differences between the median pharmacokinetic values of buspirone for healthy subjects, patients with mild to moderate renal impairment, and anuric patients were not statistically significant." | 1.27 | Clinical pharmacokinetics of oral buspirone in patients with impaired renal function. ( Caccia, S; Gammans, RE; Garattini, S; Mayol, RF; Mingardi, G; Pfeffer, M; Placchi, M; Vigano, GL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbhaiya, RH | 1 |
| Shukla, UA | 1 |
| Pfeffer, M | 2 |
| Pittman, KA | 1 |
| Shrotriya, R | 1 |
| Laroudie, C | 1 |
| Gammans, RE | 3 |
| Caccia, S | 1 |
| Vigano, GL | 1 |
| Mingardi, G | 1 |
| Garattini, S | 1 |
| Placchi, M | 1 |
| Mayol, RF | 2 |
| LaBudde, JA | 1 |
1 review available for buspirone and Kidney Diseases
| Article | Year |
|---|---|
Metabolism and disposition of buspirone.
Topics: Absorption; Administration, Oral; Adolescent; Adult; Aged; Aging; Amitriptyline; Animals; Anxiety Di | 1986 |
1 trial available for buspirone and Kidney Diseases
| Article | Year |
|---|---|
Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.
Topics: Adult; Anti-Anxiety Agents; Buspirone; Female; Humans; Kidney Diseases; Liver Cirrhosis; Liver Disea | 1994 |
1 other study available for buspirone and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of oral buspirone in patients with impaired renal function.
Topics: Administration, Oral; Adult; Buspirone; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Ki | 1988 |